Zusammenfassung
Vorhofflimmern ist die häufigste Ursache für thrombembolische Komplikationen. Das Risiko, während eines Vorhofflimmerns eine thrombembolische Komplikation zu erleiden, ist vor allen Dingen abhängig von begleitenden kardiovaskulären Risikofaktoren sowie dem Patientenalter. Bei einigen Patienten kann eine orale Antikoagulation trotz zwingender Indikation wegen gesteigerter Blutungsneigungen nicht erfolgen. Für diese selektive Gruppe von Patienten wurde u. a. ein interventioneller Verschluss des linken Herzohres als therapeutische Option postuliert. Initiale Daten hierzu wurden von herzchirurgischen Untersuchungen gewonnen, wobei der interventionelle Vorhofsohrverschluss in transseptaler Technik eine Weiterentwicklung darstellt. Nach initialen eher enttäuschenden Daten erscheinen die aktuell verfügbaren Vorhofsohrverschlusssysteme eine suffiziente Prophylaxe von thrombembolischen Komplikationen in ausgewählten Patienten zu gewährleisten.
Summary
Atrial fibrillation causes 15–20% of ischemic strokes and the overall risk of stroke in patients with non-valvular atrial fibrillation is about 5% per year globally. Warfarin has long been the cornerstone for decreasing risks of stroke in patients with atrial fibrillation and its efficacy has been well established. However, 14–44% of patients with atrial fibrillation who are at risk of stroke are ineligible for anticoagulation therapy, mostly owing to the risks of major bleeding and falls. Occlusion of the left atrial appendage (LAA) appears to be an interesting new tool to prevent thromboembolic events in selected cases. In addition to surgical techniques, percutaneous transcatheter approaches have been introduced to occlude the LAA. Recent results indicate non-inferiority of mechanical occlusion of the LAA in comparison to warfarin therapy.
Literatur
Almahameed ST, Khan M, Zuzek RW et al (2007) Left atrial appendage exclusion and the risk of thromboembolic events following mitral valve surgery. J Cardiovasc Electrophysiol 18:364–366
Blackshear JL, Odell JA (1996) Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg 61:755–759
Blackshear JL, Johnson WD, Odell JA et al (2003) Thoracoscopic extracardiac obliteration of the left atrial appendage for stroke risk reduction in atrial fibrillation. J Am Coll Cardiol 42:1249–1252
Bonow RO, Carabello BA, Chatterjee KRA et al (2008) Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 118:e523–e661
Cruz-Gonzalez I, Cubeddu RJ, Sanchez-Ledesma M et al (2008) Left atrial appendage exclusion using an Amplatzer device. Int J Cardiol
Davis CA 3rd, Rembert JC, Greenfield JC Jr (1990) Compliance of left atrium with and without left atrium appendage. Am J Physiol 259:H1006–H1008
El-Chami MF, Grow P, Eilen D et al (2007) Clinical outcomes three years after PLAATO implantation. Catheter Cardiovasc Interv 69:704–707
Ernst G, Stöllberger C, Abzieher F, Veit-Dirscherl W et al (1995) Morphology of the left atrial appendage. Anat Rec 242:553–561
Fatkin D, Kuchar DL, Thorburn CW, Feneley MP (1994) Transesophageal echocardiography before and during direct current cardioversion of atrial fibrillation: evidence for „atrial stunning“ as a mechanism of thromboembolic complications. J Am Coll Cardiol 23:307–316
Fountain RB, Holmes DR, Chandrasekaran K et al (2006) The PROTECT AF (WATCHMAN left atrial appendage system for embolic protection in patients with atrial fibrillation) trial. Am Heart J 151(5):956–961
Fukuchi M, Watanabe J, Kumagai K et al (2001) Increased von Willebrand factor in the endocardium as a local predisposing factor for thrombogenesis in overloaded human atrial appendage. J Am Coll Cardiol 37:1436–1442
Goette A, Bukowska A, Lendeckel U et al (2008) Angiotensin II receptor blockade reduces tachycardia-induced atrial adhesion molecule expression. Circulation 17:732–742
García-Fernández MA, Pérez-David E, Quiles J et al (2003) Role of left atrial appendage obliteration in stroke reduction in patients with mitral valve prosthesis: a transesophageal echocardiographic study. J Am Coll Cardiol 42:1253–1258
Camm AJ, Kirchhof P, Lip GY et al (2010) Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) European Heart Rhythm Association; European Association for Cardio-Thoracic Surgery. Eur Heart J 31:2369–2429
Healey JS, Crystal E, Lamy A et al (2005) Left Atrial Appendage Occlusion Study (LAAOS): results of a randomized controlled pilot study of left atrial appendage occlusion during coronary bypass surgery in patients at risk for stroke. Am Heart J 150:288–293
Hoit BD, Shao Y, Tsai LM et al (1993) Altered left atrial compliance after atrial appendectomy. Influence on left atrial and ventricular filling. Circ Res 72:167–175
Hoit BD, Walsh RA (1992) Regional atrial distensibility. Am J Physiol 262:H1356–H1360
Honda T, Okamoto M, Yamane T et al (1995) The role of the left atrial appendage. A volume loading study in open-chest dogs. Jpn Heart J 36:225–234
Ho IC, Neuzil P, Mraz T et al (2007) Use of intracardiac echocardiography to guide implantation of a left atrial appendage occlusion device (PLAATO). Heart Rhythm 4:567–571
Holmes DR, Reddy VY, Turi ZG, Doshi SK et al. PROTECT AF Investigators (2009) Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet 374:534–542
Jorgensen J, Palmer S, Kalogeropoulos A et al (2007) Implantation of left atrial appendage occlusion devices and complex appendage anatomy: the importance of transesophageal echocardiography. Echocardiography 24:159–161
Kamohara K, Fukamachi K, Ootaki Y et al (2006) Evaluation of a novel device for left atrial appendage exclusion: the second-generation atrial exclusion device. J Thorac Cardiovasc Surg 132:340–346
Kanderian AS, Gillinov AM, Pettersson GB et al (2008) Success of surgical left atrial appendage closure: assessment by transesophageal echocardiography. J Am Coll Cardiol 52:924–929
Katz ES, Tsiamtsiouris T, Applebaum RM et al (2000) Surgical left atrial appendage ligation is frequently incomplete: a transesophageal echocardiograhic study. J Am Coll Cardiol 36:468–471
Madden JL (1949) Resection of the left auricular appendix – a prophylaxis for recurrent arterial emboli. JAMA 140:769–772
Meier B, Palacios I, Windecker S et al (2003) Transcatheter left atrial appendage occlusion with Amplatzer devices to obviate anticoagulation in patients with atrial fibrillation. Catheter Cardiovasc Interv 60(3):417–422
Möbius-Winkler S, Schuler GC, Sick PB (2008) Interventional treatments for stroke prevention in atrial fibrillation with emphasis upon the WATCHMAN device. Curr Opin Neurol 21:64–69
Nakai T, Lesh MD, Gerstenfeld EP et al (2002) Percutaneous left atrial appendage occlusion (PLAATO) for preventing cardioembolism: first experience in canine model. Circulation 105:2217–2222
Omran H, Schmidt H, Hardung D et al (2005) Post mortem analysis of a left atrial appendage occlusion device (PLAATO) in a patient with permanent atrial fibrillation. J Interv Card Electrophysiol 14(1):17–20
Onalan O, Crystal E (2007) Left atrial appendage exclusion for stroke prevention in patients with nonrheumatic atrial fibrillation. Stroke 38:624–630
Ostermayer SH, Reisman M, Kramer PH et al (2005) Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: results from the international multi-center feasibility trials. J Am Coll Cardiol 46:9–14
Saito T, Tamura K, Uchida D et al (2007) Histopathological evaluation of left atrial appendage thrombogenesis removed during surgery for atrial fibrillation. Am Heart J 153:704–711
Schwartzman D, Katz WE, Smith AJ, Anderson WD (2007) Malpositioning of a left atrial appendage occlusion device? A case with implications for percutaneous transcatheter left atrial appendage occlusion device therapy. Heart Rhythm 4:648–650
Sick PB, Schuler G, Hauptmann KE et al (2007) Initial worldwide experience with the WATCHMAN left atrial appendage system for stroke prevention in atrial fibrillation. J Am Coll Cardiol 49:1490–1495
Sievert H, Lesh MD, Trepels T et al (2002) Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation: early clinical experience. Circulation 105:1887–1879
Stöllberger C, Schneider B, Finsterer J (2007) Serious complications from dislocation of a Watchman left atrial appendage occluder. J Cardiovasc Electrophysiol 18:880–881
Syed TM, Halperin JL (2007) Left atrial appendage closure for stroke prevention in atrial fibrillation: state of the art and current challenges. Nat Clin Pract Cardiovasc Med 4:428–435
Tabata T, Oki T, Yamada H et al (1998) Role of left atrial appendage in left atrial reservoir function as evaluated by left atrial appendage clamping during cardiac surgery. Am J Cardiol 81:327–332
Veinot JP, Harrity PJ, Gentile F et al (1997) Anatomy of the normal left atrial appendage: a quantitative study of age-related changes in 500 autopsy hearts: implications for echocardiographic examination. Circulation 96:3112–3115
Yamashita T, Sekiguchi A, Iwasaki YK et al (2003) Thrombomodulin and tissue factor pathway inhibitor in endocardium of rapidly paced rat atria. Circulation 108:2450–2452
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Goette, A. Techniken zum Verschluss des linken Herzohres. Nervenarzt 82, 172–179 (2011). https://doi.org/10.1007/s00115-010-3113-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00115-010-3113-6